Adjuvant Capital
2026-09-01adjuvantcapital.com
Overview
What they do
Adjuvant Capital is a life sciences investment firm focused on global health and public health technologies. It finances promising life science innovations addressing high-burden and neglected diseases, maternal and child health, nutrition, and reproductive and sexual health, often through preferred equity investments in technologies with demonstrated safety and efficacy in humans. The firm aims to leverage venture capital strategies to generate both social and financial returns by accelerating the global availability of impactful medical innovations and ensuring access for those who need them most.
adjuvantcapital.com
What they look for
Adjuvant Capital is a venture capital firm investing $10-$25 million in life sciences companies developing public health technologies for high-burden and neglected diseases and related health areas. Its strategy focuses on using preferred equity investments to back innovations with proven human safety and efficacy, with an emphasis on global health impact and accessibility.
adjuvantcapital.com
Stage
Series A, Series B+
adjuvantcapital.com
Sectors
Healthcare
adjuvantcapital.com
Based
New York, US
adjuvantcapital.com
Sources
2026-09-01adjuvantcapital.comFortified snacks to address maternal and childhood malnutrition in Bangladesh.
2026-09-01adjuvantcapital.comGlenn Rockman Co-Founder and Partner New York Adjuvant Global Health Technology Fund
Portfolio, cheque size and the rest
The 19 companies they have backed that we can see, the cheque they write, and whether they are deploying right now.
Start free, no cardFree accounts see every record.